STRS Ohio’s Rubius Therapeutics, Inc RUBY Stock Holding History

STRS Ohio’s Portfolio RUBY Stock Details RUBY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,400	Closed	-$42K	–	2330
2021 Q3	$42K	Sell	2,400 -3,600	-60%	-$78.3K	﹤0.01%	2098
2021 Q2	$146K	Buy	+6,000	New	+$150K	﹤0.01%	1892
2019 Q2	–	Sell	-3,500	Closed	-$63K	–	2242
2019 Q1	$63K	Hold	3,500	–	–	﹤0.01%	1853
2018 Q4	$56K	Hold	3,500	–	–	﹤0.01%	1863
2018 Q3	$84K	Buy	+3,500	New	+$80K	﹤0.01%	1860

Other funds holding RUBY

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

STRS Ohio's RUBY Position: Q4 2021 in Review

STRS Ohio sold out of Rubius Therapeutics, Inc (RUBY) in Q4 2021, closing a stake of 2,400 shares — an estimated $42K sold.

STRS Ohio first reported a position in RUBY in Q3 2018 and held it in 5 quarters. The position peaked at $146K in Q2 2021. 108 funds tracked by Wall St. Rank hold RUBY as of Q4 2021.

STRS Ohio reported no remaining Rubius Therapeutics, Inc position as of Q4 2021 after selling out during the quarter.
STRS Ohio sold 2,400 Rubius Therapeutics, Inc shares in Q4 2021, an estimated $42K.
STRS Ohio first reported a position in Rubius Therapeutics, Inc in Q3 2018 and held it in 5 quarters.
STRS Ohio's Rubius Therapeutics, Inc position peaked at $146K in Q2 2021.
108 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q4 2021.

Based on STRS Ohio's 13F filing for Q4 2021, filed 24 Jan 2022.